Antiarrhythmic drugs in resuscitation

Heart

Volumn 80, Issue 4, 1998, Pages 408-411

  Chamberlain, D A ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; BRETYLIUM; CALCIUM CHLORIDE; ENCAINIDE; FLECAINIDE; LIDOCAINE; MAGNESIUM SULFATE; MEXILETINE; MORACIZINE; NORADRENALIN; POTASSIUM CHLORIDE; PROCAINAMIDE; QUINIDINE;

CARDIOPULMONARY INSUFFICIENCY; DEFIBRILLATION; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEMODYNAMIC MONITORING; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RESUSCITATION; REVIEW; TREATMENT INDICATION;

EID: 0031682254     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.80.4.408     Document Type: Review

References (45)

1. Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996.
2. Lie KI, Wellens HJ, van Capelle FJ, et al. Lidocaine to prevent death in early phase of acute infarction. N Engl J Med 1974;25:1324-6.
3. Koster RW, Dunning AJ. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 1985;313:1105-10.
4. MacMahon S, Collins R, Peto R, et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction. JAMA 1988;260:1910-16.
5. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.
6. Hine LK, Laird NL, Hewitt P, et al. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 1989;149:2694-8.
7. Valentine PA, Frew JL, Mashford ML, et al. Lidocaine to prevent death in early phase of acute infarction. N Engl J Med 1974;291:1327-31.
8. Babbs CF, Yim GKW, Tacker WA, et al. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. Am Heart J 1979;98:345-50.
9. Chow MSS, Kluger J, Lawrence R, et al. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proc Soc Exp Biol Med 1986;182:63-7.
10. Kerber RE, Pandian NG, Jensen SR, et al. The effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. J Am Coll Cardiol 1986;7:397-405.
11. Dorian P, Fain ES, Davey J-M, et al. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. J Am Coll Cardiol 1986;8:327-32.
12. Topham SL, Cha Y-M, Peters BB, et al. Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs. Circulation 1992;85: 1146-51.
13. Kerber RE, Jensen SR, Gascho, JA, et al. Determinants of defibrillation: prospective analysis of 183 patients. Am J Cardiol 1983;52:739-45.
14. Harrison EE. Lidocaine in prehospital countershock refractory ventricular fibrillation. Ann Emerg Med 1981;10:420-3.
15. Weaver WD, Fahrenbruch CE, Johnson DD, et al. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 1990;82:2027-34.
16. Herlitz J, Ekström L, Wennerblom B, et al. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? Resuscitation 1997;33:199-205.
17. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA 1992;268:2171-295.
18. Davy J-M, Fain ES, Dorian P, et al. The relationship between successful defibrillation and delivered energy in open-chested dogs: reappraisal of the "defibrillation threshold" concept. Am Heart J 1987;113:77-84.
19. Hernandez R, Mann DE, Breckinridge S, et al. Effects of flecainide on defibrillation thresholds in the anesthetized dog. J Am Coll Cardiol 1989;14:777-81.
20. Marinchak RA, Friehling TD, Kline RA, et al. Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature. PACE 1988;11:7-12.
21. Fain ES, Dorian P, Davy J-M, et al. Effects of encainide and its metabolites on energy requirements for defibrillation. Circulation 1986;73:1334-41.
22. Avitall B, Hare J, Zander G, et al. Cardioversion, defibrillation, and overdrive pacing of ventricular arrhythmias: the effect of moricizine in dogs with sustained monomorphic ventricular tachycardia. PACE 1993;16:2092-7.
23. Dorian P, Fain ES, Davy J-M, et al. Effect of quinidine and bretylium on defibrillation energy requirements. Am Heart J 1986;112:19-25.
24. Echt DS, Black JN, Barbey JT, et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. Circulation 1989;79:1106-17.
25. Fain ES, Lee JT, Winkle RA. Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements. Am Heart J 1987;114:8-17.
26. Anastasiou-Nana MI, Nanas JN, Nanas SN, et al. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study. J Am Coll Cardiol 1994;23:253-8.
27. Jung W, Manz M, Pizzulli L, et al. Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol 1992;70:1023-7.
28. Huang SKS, Tan de Guzman WL, Chenarides JG, et al. Effects of long-term amiodarone therapy on the defibrillation threshold and the rate of shocks of the implantable cardioverter-defibrillator. Am Heart J 1991;122:720-7.
29. Williams ML, Woelfel A, Cascio WE, et al. Intravenous amiodarone during prolonged resuscitation from cardiac arrest. Ann Intern Med 1989;110:839-42.
30. Cardinal R, Sasyniuk BI. Electrophysiological effects of bretylium tosylate on subendocardial Purkinje fibers from infarcted canine hearts. J Pharmacol Exp Ther 1978;204: 159-74.
31. Sanna G, Arcidiacono R. Chemical ventricular defibrillation of the human heart with bretylium tosylate. Am J Cardiol 1973;32:982-7.
32. Bacaner MB. Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate. Am J Cardiol 1968;21:530-43.
33. Nowak RM, Bodnar TJ, Dronen S, et al. Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo. Ann Emerg Med 1981;10:404-7.
34. Haynes RE, Chinn TL, Copass MK, et al. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Am J Cardiol 1981;48:353-6.
35. Olson DW, Thompson BM, Darin JC, et al. A randomized comparison of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 1984;13:807-61.
36. Tobey RC, Birnbaum GA, Allegra JR, et al. Successful resuscitation and neurologic recovery from refractory ventricular fibrillation after magnesium sulphate administration. Ann Emerg Med 1992;21:92-6.
37. Lindner KH, Ahnefeld FW, Dirks B, et al. Lidocainkonzentrationen im plasma nach peripher- bzw. zentralvenöser applikation während der kardiopulmonalen reanimation. Ergebnisse einer tierexperimentellen studie. Anaesthesist 1989;38:604-9.
38. Ujhelyi MR, Schur M, Frede T, et al. Differential effects of lidocaine on defibrillation threshold with monophasic versus biphasic shock waveforms. Circulation 1995;92:1644-50.
39. Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulphate. Circulation 1988;77: 392-7.
40. Clayton RH, Murray A, Higham PD, et al. Self-terminating ventricular tachyarrhythmias - a diagnostic dilemma? Lancet 1993;341:93-5.
41. Chamberlain D. Peri-arrest arrhythmias. Br J Anaesth 1997; 79:198-202.
42. Steuven HA, Thompson B, Aprahamian C, et al. The effectiveness of calcium chloride in refractory electromechanical dissociation. Ann Emerg Med 1985;14:626-9.
43. Steuven HA, Thompson B, Aprahamian C, et al. Lack of effectiveness of calcium chloride in refractory asystole. Ann Emerg Med 1985;14:630-2.
44. Cairns CB, Niemann JT, Pelikan PCD, et al. Ionized hypocalcemia during prolonged cardiac arrest and closed-chest CPR in a canine model. Ann Emerg Med 1991;20:1178-82.
45. Urban P, Scheidegger D, Buchmann B, et al Cardiac arrest and blood ionized calcium levels. Ann Intern Med 1988;109:110-13.